Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Abstract

Attitudes toward LAIs need to be considered when deciding whether to prescribe this formulation. Access to information on LAIs, including their benefit in relapse prevention, might enhance the acceptance and use of this formulation among patients with schizophrenia.